In a previous study published in 2009, we examined the diagnostic performance of Blue-on-Yellow pattern onset stimulation and mfVEP in preperimetric glaucoma, and reported nearly 50% sensitivity.
12 Subsequently, to elucidate the mechanism for the effective performance of BonY stimulation (whether luminance or chromatic properties) we compared the sensitivities of pattern-onset high luminance achromatic (HLA), LLA (an achromatic stimulus with luminance contrast similar to the BonY stimulus), and BonY stimulation in a group of patients with early but perimetrically proven glaucoma (MD < 6 dB) and found that LLA was similar to BonY, and both performed significantly better that HLA stimulation.
13 The current study examined the diagnostic performance of LLA mfVEP in preperimetric glaucoma, and also compared it to other commonly used early diagnostic methods in glaucoma.
We found that LLA mfVEP had almost the same sensitivity as HRT, with slightly, though not significantly, better specificity. The advantage of the LLA mfVEP over the HRT, however, is that it is a functional test that is able to demonstrate loss of visual function, lending more confidence to the diagnosis of glaucoma, particularly while contemplating therapy. The demonstration of visual defects, which corresponded topographically to disc changes, added further confidence to the diagnosis. Currently available alternative methods of demonstrating visual field defects in preperimetric glaucoma, that is, SWAP and FDT, demonstrated sensitivities of 21.2% and 18.8%, respectively, similar to what has been reported previously.
20 The LLA mfVEP demonstrated much higher sensitivity (50.6%), which is a fairly high value considering that we are dealing with glaucoma that is so early that defects have not yet been demonstrated on conventional SAP.
In a previous study, where we examined the LLA stimulus for the first time and compared it to high contrast stimulation, we demonstrated that the LLA mfVEP identified defects in 90% eyes with early perimetric glaucoma (MD < 6 dB), with 96% specificity. It performed significantly better than the achromatic high contrast stimulus. Multifocal VEP responses to achromatic stimulation saturate at approximately 40% to 50% luminance contrast,
21–23 which is similar to what we used in this study for LLA. Response at this level of luminance contrast has been described previously to have predominant magnocellular contributions. The parvocellular pathway, which constitutes approximately 80% of retinal ganglion cells is responsible for processing of high contrast, low temporal, and high spatial frequency information (achromatic high luminance contrast stimuli) while the magnocellular pathway conveys information about low contrast and low spatial frequency achromatic images, and has higher temporal resolution. For subjective functional tests, using stimuli that preferentially target the magnocellular pathways, has been shown to enable earlier identification of scotomas
24 due to lower functional redundancy in cells subserving these pathways,
25,26 since each of these pathways constitutes, on average, only approximately 10% of the ganglion cell population.
27,28 This preferential stimulation of the magnocellular pathway may explain the excellent performance of the LLA stimulus.
The rationale for combining tests to examine their combined diagnostic performance was to try and maximize sensitivity. The combination of one structural with one functional test is commonly practiced and is feasible in most clinical situations. The combination of HRT and LLA mfVEP yielded the best sensitivity of 76.5% while maintaining 82.4% specificity. This combination also had the best negative predictive value of 84% (at a presumed glaucoma prevalence of 40%), and a PPV of 74%, meaning that when both tests are negative, there is an 84% chance that the eye is not glaucomatous, but that if one of the tests is positive, there is a 74% chance that the eye does have glaucoma. Therefore, this combination is of better value in ruling out disease when negative.
The best positive predictive value for any single test or combination was seen with the OCT, which was 100%. However, sensitivity of the test was quite low at 23%. Addition of FDT-Matrix to the OCT improved sensitivity to 35%, while reducing PPV to approximately 90%. This combination may be useful in situations where high PPV is desired, for example, while considering second or third line medications, or when the risks of treating inappropriately outweigh the risks of not treating early disease that may exist.
The fact that we defined abnormality in structural tests as “abnormal” rather than “borderline” classification may have unfairly limited the sensitivity of the Spectralis OCT, but may have favored the HRT, which is more dependent on cup shape. On the other hand one could argue that since the diagnosis was made on a clinical impression from a disc photo, it may reflect some overdiagnosis by us of physiologically large cups as preperimetric glaucoma.
Although the use of both eyes of the patients is not ideal from a statistical viewpoint, it represents a real-life situation that is very common. It is the nature and a fallacy of the asymmetry analysis that it is dependent on both eyes, in this study as well as in real life. However, the use of both eyes of patients, whether preperimetric in both eyes, or representing glaucoma perimetric changes in one eye, if anything, reduces the sensitivity of the technique resulting in underestimation of defects, never overestimation. This is because, if both eyes were affected, but one eye more than the other, as happens typically in glaucoma, the lesser affected eye could be flagged as normal by the asymmetry analysis even though it is not really normal, just lesser affected. Unless amplitude analysis identifies the defect, that particular defect will be missed. There is no way asymmetry analysis will overdiagnose glaucoma in this situation, it will only underdiagnose. However, as already mentioned, bilaterality and asymmetry are inherent attributes of the disease, and preperimetric glaucoma more often than not is present in contralateral eyes of patients with perimetric glaucoma in one eye, and the purpose of the study was to examine the utilities of these tests in real-life situations.
It also was not ideal to use both eyes of control patients. This was done for logistic reasons. However, again this actually reduced specificity of the test rather than increased it. One subject had bilateral scotomas as a result of cortical convolutions, which was counted as a defect nevertheless for specificity calculations, therefore as two defects even though they existed in the same subject.
Preperimetric glaucoma is a challenging clinical situation, and its management is rendered more difficult by the imperfections of diagnostic tests currently available. The strength of the current study, however, is its focus on clinical relevance of results of these tests. The results of this study are directly applicable to clinical situations. The combinations of tests studied are feasible in most situations, and most clinicians would use a combination of at least one structural and one functional test for baseline evaluation and follow-up of these patients.
In conclusion, LLA mfVEP identified 50.6% eyes with preperimetric glaucoma, which was significantly higher than other perimetric methods, and similar to the HRT. The combination of LLA mfVEP and HRT had exceptionally high sensitivity of 76.5% for preperimetric glaucoma and better negative than positive predictive value. The OCT had very high specificity and PPV, with, however, significantly lower sensitivity. The Matrix-OCT combination had somewhat better sensitivity at 35.3%, and high PPV (90%). Longitudinal studies of these patients are currently underway to examine how the different tests predict the future conversion of preperimetric to perimetric glaucoma.